Skip to main content
Clinical Trials/ACTRN12616001476426
ACTRN12616001476426
Completed
N/A

The impact of cognitive remediation on cognitive and self-reported psychosocial outcomes in individuals with schizophrenia or schizoaffective disorder

Monash University0 sites56 target enrollmentOctober 24, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
Monash University
Enrollment
56
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 24, 2016
End Date
March 31, 2017
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of schizophrenia or schizoaffective disorder
  • \- Aged between 18\-65
  • \- Participants clinically stable with no acute psychosis requiring hospitalisation within the last 8 weeks
  • \- Fluency in English with an ability to comprehend research material

Exclusion Criteria

  • \- Estimated intelligence quotient (IQ) of less than 80 (i.e. Borderline IQ or lower)
  • \- History of any significant neurological injury or neurodegenerative disease known to impact cognition.
  • \- Currently pregnant
  • \- Substance dependence in the past 6 months
  • \- Electroconvulsive therapy in the past 6 months
  • \- Participation in any cognitively\-enhancing research trial or intervention
  • \- Significant sensory or motor impairments that may impact ability to use computers

Outcomes

Primary Outcomes

Not specified

Similar Trials